Cargando…
The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
Autores principales: | Honore, Patrick M., Mugisha, Aude, Kugener, Luc, Redant, Sebastien, Attou, Rachid, Gallerani, Andrea, De Bels, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218617/ https://www.ncbi.nlm.nih.gov/pubmed/32404187 http://dx.doi.org/10.1186/s13054-020-02947-x |
Ejemplares similares
-
Austrian recommendations for best clinical practice in case of haemorrhagic traumatic brain injury under platelet inhibitors or non-vitamin K antagonist oral anticoagulants: an additional therapeutic option to consider
por: Honore, Patrick M., et al.
Publicado: (2020) -
High doses of ketamine to improve neuronal edema in subarachnoid hemorrhage: we should consider other undesirable organ targets
por: Honore, Patrick M., et al.
Publicado: (2020) -
With the current COVID pandemic: should we use single-use flexible bronchoscopes instead of conventional bronchoscopes?
por: Honore, Patrick M., et al.
Publicado: (2020) -
Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020) -
The causal link between hyperchloremia and acute kidney injury is yet to be conclusively established: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)